The DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome?
Open accessAbstract
Safe and efficient drugs to combat the current COVID-19 pandemic are urgently needed. In this context, we have analyzed the anti-coronavirus potential of the natural product glycyrrhizic acid (GLR), a drug used to treat liver diseases (including viral hepatitis) and specific cutaneous inflammation (such as atopic dermatitis) in some countries. The properties of GLR and its primary active metabolite glycyrrhetinic acid are presented and discussed. GLR has shown activities against different viruses, including SARS-associated Human and animal coronaviruses. GLR is a non-hemolytic saponin and a potent immuno-active anti-inflammatory agent which displays both cytoplasmic and membrane effects. At the membrane level, GLR induces cholesterol-dependent disorganization of lipid rafts which are important for the entry of coronavirus into cells. At the intracellular and circulating levels, GLR can trap the high mobility group box 1 protein and thus blocks the alarmin functions of HMGB1. We used molecular docking to characterize further and discuss both the cholesterol- and HMG box-binding functions of GLR. The membrane and cytoplasmic effects of GLR, coupled with its long-established medical use as a relatively safe drug, make GLR a good candidate to be tested against the SARS-CoV-2 coronavirus, alone and in combination with other drugs. The rational supporting combinations with (hydroxy)chloroquine and tenofovir (two drugs active against SARS-CoV-2) is also discussed. Based on this analysis, we conclude that GLR should be further considered and rapidly evaluated for the treatment of patients with COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Gautret, P., Lagier, J.-C., Parola, P., Hoang, V. T., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Vieira, V. E., et al. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105949 · Cited by 5,288
RetractedCarafa, M., Marianecci, C., Rinaldi, F., Marzio, L. D., Mastriota, M., Pieretti, S., Celia, C., Paolino, D., Iannone, M., & Fresta, M. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s55066 · Cited by 52
RetractedYao, X., Ye, F., Zhang, M., Cui, C., Huang, B., Niu, P., Liu, X., Zhao, L., Dong, E., Song, C., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa237 · Cited by 2,662
Gao, J., Tian, Z., & Yang, X. (2020) · BioScience Trends · doi:10.5582/bst.2020.01047 · Cited by 2,590
Wu, C., Liu, Y., Yang, Y., Zhang, P., Zhong, W., Wang, Y., Wang, Q., Xu, Y., Li, M., Li, X., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.02.008 · Cited by 2,330
Liu, J., Cao, R., Xu, M., Wang, X., Zhang, H., Hu, H., Li, Y., Hu, Z., Zhong, W., & Wang, M. (2020) · Cell Discovery · doi:10.1038/s41421-020-0156-0 · Cited by 2,070
Discovering drugs to treat coronavirus disease 2019 (COVID-19)
Dong, L., Hu, S., & Gao, J. (2020) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2020.01012 · Cited by 1,390
A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19
Cortegiani, A., Ingoglia, G., Ippolito, M., Giarratano, A., & Einav, S. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.03.005 · Cited by 1,160
Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus
Cinatl, J., Morgenstern, B., Bauer, G., Chandra, P., Rabenau, H., & Doerr, H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13615-x · Cited by 1,158
Devaux, C. A., Rolain, J.-M., Colson, P., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105938 · Cited by 1,099
The epidemiology, diagnosis and treatment of COVID-19
Zhai, P., Ding, Y., Wu, X., Long, J., Zhong, Y., & Li, Y. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105955 · Cited by 1,014
Elfiky, A. A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117592 · Cited by 923
Liquorice ( Glycyrrhiza glabra ): A phytochemical and pharmacological review
Pastorino, G., Cornara, L., Soares, S., Rodrigues, F., & Oliveira, M. B. P. P. (2018) · Phytotherapy Research · doi:10.1002/ptr.6178 · Cited by 804
The novel coronavirus outbreak in Wuhan, China
Zhu, H., Wei, L., & Niu, P. (2020) · Global Health Research and Policy · doi:10.1186/s41256-020-00135-6 · Cited by 736
Wang, H., Yang, P., Liu, K., Guo, F., Zhang, Y., Zhang, G., & Jiang, C. (2008) · Cell Research · doi:10.1038/cr.2008.15 · Cited by 707
Glycyrrhizin Binds to High-Mobility Group Box 1 Protein and Inhibits Its Cytokine Activities
Mollica, L., De Marchis, F., Spitaleri, A., Dallacosta, C., Pennacchini, D., Zamai, M., Agresti, A., Trisciuoglio, L., Musco, G., & Bianchi, M. E. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.03.007 · Cited by 612
Fantini, J., Di Scala, C., Chahinian, H., & Yahi, N. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105960 · Cited by 561
Rainsford, K. D., Parke, A. L., Clifford-Rashotte, M., & Kean, W. F. (2015) · Inflammopharmacology · doi:10.1007/s10787-015-0239-y · Cited by 543
In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds
Chen, F., Chan, K. H., Jiang, Y., Kao, R. Y. T., Lu, H. T., Fan, K. W., Cheng, V. C. C., Tsui, W. H. W., Hung, I. F. N., & Lee, T. S. W. (2004) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.03.003 · Cited by 534
El-Saber Batiha, G., Magdy Beshbishy, A., El-Mleeh, A., M. Abdel-Daim, M., & Prasad Devkota, H. (2020) · Biomolecules · doi:10.3390/biom10030352 · Cited by 461
Molecular modeling of organic and biomolecular systems using BOSS and MCPRO
Jorgensen, W. L., & Tirado–Rives, J. (2005) · Journal of Computational Chemistry · doi:10.1002/jcc.20297 · Cited by 432
Antiviral Activity of Glycyrrhizic Acid Derivatives against SARS−Coronavirus
Hoever, G., Baltina, L., Michaelis, M., Kondratenko, R., Baltina, L., Tolstikov, G. A., Doerr, H. W., & Cinatl, J. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0493008 · Cited by 416
Structure of the HMG box motif in the B-domain of HMG1.
Weir, H. M., Kraulis, P. J., Hill, C. S., Raine, A. R., Laue, E. D., & Thomas, J. O. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05776.x · Cited by 403
An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies
Musumeci, D., Roviello, G. N., & Montesarchio, D. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.11.001 · Cited by 334
Glycyrrhizic Acid in the Treatment of Liver Diseases: Literature Review
Li, J.-Y., Cao, H.-Y., Liu, P., Cheng, G.-H., & Sun, M.-Y. (2014) · BioMed Research International · doi:10.1155/2014/872139 · Cited by 271
Lipid rafts are involved in SARS-CoV entry into Vero E6 cells
Lu, Y., Liu, D. X., & Tam, J. P. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.02.023 · Cited by 269
Toxicological Effects of Glycyrrhiza glabra (Licorice): A Review
Nazari, S., Rameshrad, M., & Hosseinzadeh, H. (2017) · Phytotherapy Research · doi:10.1002/ptr.5893 · Cited by 266
Natural products in licorice for the therapy of liver diseases: Progress and future opportunities
Li, X., Sun, R., & Liu, R. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.04.025 · Cited by 256
Briolant, S., Garin, D., Scaramozzino, N., Jouan, A., & Crance, J. M. (2004) · Antiviral Research · doi:10.1016/j.antiviral.2003.09.005 · Cited by 252
Glycyrrhizic‐Acid‐Based Carbon Dots with High Antiviral Activity by Multisite Inhibition Mechanisms
Tong, T., Hu, H., Zhou, J., Deng, S., Zhang, X., Tang, W., Fang, L., Xiao, S., & Liang, J. (2020) · Small · doi:10.1002/smll.201906206 · Cited by 249
Selyutina, O. Y., & Polyakov, N. E. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.01.047 · Cited by 246
Teicoplanin: an alternative drug for the treatment of COVID-19?
Baron, S. A., Devaux, C., Colson, P., Raoult, D., & Rolain, J.-M. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105944 · Cited by 243
HMGB1 as biomarker and drug target
Venereau, E., De Leo, F., Mezzapelle, R., Careccia, G., Musco, G., & Bianchi, M. E. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.06.031 · Cited by 240
Therapeutic Effects of Glycyrrhizic Acid
Ming, L. J., & Yin, A. C. Y. (2013) · Natural Product Communications · doi:10.1177/1934578x1300800335 · Cited by 197
Therapeutic basis of glycyrrhizin on chronic hepatitis B
SATO, H., GOTO, W., YAMAMURA, J., KUROKAWA, M., KAGEYAMA, S., TAKAHARA, T., WATANABE, A., & SHIRAKI, K. (1996) · Antiviral Research · doi:10.1016/0166-3542(96)00942-4 · Cited by 185
Li, G.-M., Li, Y.-G., Yamate, M., Li, S.-M., & Ikuta, K. (2007) · Microbes and Infection · doi:10.1016/j.micinf.2006.10.015 · Cited by 185
Glycyrrhizin as antiviral agent against Hepatitis C Virus
Ashfaq, U. A., Masoud, M. S., Nawaz, Z., & Riazuddin, S. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-112 · Cited by 185
Antiviral activity of glycyrrhizin against varicella-zoster virus in vitro
Baba, M., & Shigeta, S. (1987) · Antiviral Research · doi:10.1016/0166-3542(87)90025-8 · Cited by 184
Dai, C., Xiao, X., Li, D., Tun, S., Wang, Y., Velkov, T., & Tang, S. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-1136-2 · Cited by 182
Mason, R. P., Jacob, R. F., Shrivastava, S., Sherratt, S. C. R., & Chattopadhyay, A. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2016.10.002 · Cited by 179
Fibrillar Networks of Glycyrrhizic Acid for Hybrid Nanomaterials with Catalytic Features
Saha, A., Adamcik, J., Bolisetty, S., Handschin, S., & Mezzenga, R. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201411875 · Cited by 175
Zhao, X., Jiang, Y., Zhao, Y., Xi, H., Liu, C., Qu, F., & Feng, X. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03897-6 · Cited by 173
Glycyrrhizin inhibits influenza A virus uptake into the cell
Wolkerstorfer, A., Kurz, H., Bachhofner, N., & Szolar, O. H. J. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.04.012 · Cited by 172
Kwon, Y.-J., Son, D.-H., Chung, T.-H., & Lee, Y.-J. (2020) · Journal of Medicinal Food · doi:10.1089/jmf.2019.4459 · Cited by 165
Michaelis, M., Geiler, J., Naczk, P., Sithisarn, P., Leutz, A., Doerr, H. W., & Cinatl, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019705 · Cited by 164
Glycyrrhizic acid: A promising carrier material for anticancer therapy
Su, X., Wu, L., Hu, M., Dong, W., Xu, M., & Zhang, P. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.08.123 · Cited by 164
Alagawany, M. M., Elnesr, S. S., Farag, M. R., El-Hack, M. E. A., Khafaga, A. F., Taha, A. E.-S., Tiwari, R., Yatoo, M. I., Bhatt, P., Gopi, M., et al. (2019) · Animals · doi:10.3390/ani9080536 · Cited by 154
18β‐Glycyrrhetinic acid: its core biological properties and dermatological applications
Kowalska, A., & Kalinowska‐Lis, U. (2019) · International Journal of Cosmetic Science · doi:10.1111/ics.12548 · Cited by 152
Glycyrrhetinic Acid Mediated Drug Delivery Carriers for Hepatocellular Carcinoma Therapy
Cai, Y., Xu, Y., Chan, H. F., Fang, X., He, C., & Chen, M. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00677 · Cited by 150
Harada, S. (2005) · Biochemical Journal · doi:10.1042/bj20051069 · Cited by 143
Pharmacological perspective: glycyrrhizin may be an efficacious therapeutic agent for COVID-19
Luo, P., Liu, D., & Li, J. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105995 · Cited by 142
Inhibition of hepatitis C virus replication by chloroquine targeting virus-associated autophagy
Mizui, T., Yamashina, S., Tanida, I., Takei, Y., Ueno, T., Sakamoto, N., Ikejima, K., Kitamura, T., Enomoto, N., Sakai, T., et al. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-009-0132-9 · Cited by 141
Antiviral Activity of Glycyrrhizin against Hepatitis C Virus In Vitro
Matsumoto, Y., Matsuura, T., Aoyagi, H., Matsuda, M., Hmwe, S. S., Date, T., Watanabe, N., Watashi, K., Suzuki, R., Ichinose, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068992 · Cited by 140
Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice
Sitia, G., Iannacone, M., Müller, S., Bianchi, M. E., & Guidotti, L. G. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306173 · Cited by 139
Chen, L., Hu, C., Hood, M. M., Zhang, X., Zhang, L., Kan, J., & Du, J. C. (2020) · Nutrients · doi:10.3390/nu12041193 · Cited by 135
Yang, F., Zhang, Q., Liang, Q., Wang, S., Zhao, B., Wang, Y.-T., Cai, Y., & Li, G. (2015) · Molecules · doi:10.3390/molecules20034337 · Cited by 130
Chen, X., Wang, K., Xing, Y., Tu, J., Yang, X., Zhao, Q., Li, K., & Chen, Z. (2014) · Protein & Cell · doi:10.1007/s13238-014-0104-6 · Cited by 130
Sun, X., Zeng, H., Wang, Q., Yu, Q., Wu, J., Feng, Y., Deng, P., & Zhang, H. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.05.012 · Cited by 130
Preliminary evidence for inhibitory effect of glycyrrhizin on HIV replication in patients with AIDS
Hattori, T., Ikematsu, S., Koito, A., Matsushita, S., Maeda, Y., Hada, M., Fujimaki, M., & Takatsuki, K. (1989) · Antiviral Research · doi:10.1016/0166-3542(89)90035-1 · Cited by 127
Li, Q., He, Q., Xu, M., Li, J., Liu, X., Wan, Z., & Yang, X. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b04957 · Cited by 123
Baglivo, M., Baronio, M., Natalini, G., Beccari, T., Chiurazzi, P., Fulcheri, E., Petralia, P., Michelini, S., Fiorentini, G., Miggiano, G. A. D., et al. (2020) · PubMed Central · doi:10.23750/abm.v91i1.9402 · Cited by 123
Castangia, I., Caddeo, C., Manca, M. L., Casu, L., Catalán-Latorre, A., Dı́ez-Sales, O., Ruiz‐Saurí, A., Bacchetta, G., Fadda, A. M., & Manconi, M. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2015.08.037 · Cited by 122
Aggregate formation of glycyrrhizic acid
Matsuoka, K., Miyajima, R., Ishida, Y., Karasawa, S., & Yoshimura, T. (2016) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2016.04.032 · Cited by 118
Severe Acute Lung Injury Related to COVID‐19 Infection: A Review and the Possible Role for Escin
Gallelli, L., Zhang, L., Wang, T., & Fu, F. (2020) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1644 · Cited by 118
HMGB1 Protein Binds to Influenza Virus Nucleoprotein and Promotes Viral Replication
Moisy, D., Avilov, S., Jacob, Y., Laoide, B. M., Ge, X., Baudin, F., Naffakh, N., & Jestin, J. (2012) · Journal of Virology · doi:10.1128/jvi.00789-12 · Cited by 116
Wang, C., Chen, L., Xu, C., Shi, J., Chen, S., Tan, M., Chen, J., Zou, L., Chen, C., Liu, Z., et al. (2020) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x20500020 · Cited by 115 · cited 1×
“In addition to HMG proteins, GLR has also been shown to bind to other proteins such as serum albumin (Wang et al., 2020; Wang et al., 2020; Wang, Shan, & Lü, 2020) and to recombinant HIV-1 reverse transcriptase to inhibit the protein phosphorylation (Harada et al.”
Wan, Z., Sun, Y., Ma, L., et al. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6b05242 · Cited by 113
Choi, K. S., Aizaki, H., & Lai, M. M. C. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9862-9871.2005 · Cited by 111
Cholesterol-lowering effect of platycodin D in hypercholesterolemic ICR mice
Zhao, H. L., Cho, K., Ha, Y. W., Jeong, T., Lee, W. S., & Kim, Y. S. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.03.032 · Cited by 110
Chloroquine inhibits HMGB1 inflammatory signaling and protects mice from lethal sepsis
Yang, M., Cao, L., Xie, M., Yu, Y., Kang, R., Yang, L., Zhao, M., & Tang, D. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.05.013 · Cited by 110
Advances in Pharmacological Activities and Mechanisms of Glycyrrhizic Acid
Chen, K., Yang, R., Shen, F.-Q., & Zhu, H. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867325666191011115407 · Cited by 110
Potential Neuroprotective Effect of the HMGB1 Inhibitor Glycyrrhizin in Neurological Disorders
Paudel, Y. N., Angelopoulou, E., Semple, B. D., Piperi, C., Othman, I., & Shaikh, M. F. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00640 · Cited by 110
Wei, X., She, G., Wu, T., Xue, C., & Cao, Y. (2020) · Veterinary Research · doi:10.1186/s13567-020-0739-7 · Cited by 109
Sasaki, H., Takei, M., Kobayashi, M., Pollard, R. B., & Suzuki, F. (2002) · Pathobiology · doi:10.1159/000069334 · Cited by 108
Wan, Z., Sun, Y., Ma, L., et al. (2016) · Food & Function · doi:10.1039/c6fo01485b · Cited by 107
Guo, H., Huang, M., Yuan, Q., Wei, Y., Gao, Y., Mao, L., Lingjun, G., Tan, Y. W., Zhong, Y., Liu, D. X., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170123 · Cited by 98
Qu, L., Chen, C., He, W., Chen, Y., Li, Y., Wen, Y., Zhou, S., Jiang, Y., Yang, X., Zhang, R., et al. (2019) · PubMed · Cited by 98
Michaelis, M., Geiler, J., Naczk, P., Sithisarn, P., Ogbomo, H., Altenbrandt, B., Leutz, A., Doerr, H. W., & Cinatl, J. J. (2010) · Medical Microbiology and Immunology · doi:10.1007/s00430-010-0155-0 · Cited by 97
Wang, R., Wu, W., Li, W., Huang, S., Li, Z., Liu, R.-M., Shan, Z., Zhang, C., Li, W., & Wang, S. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.008596 · Cited by 95
Chen, H., Guan, B., Wang, B., Pu, H.-W., Bai, X., Chen, X., Liu, J., Li, C., Qiu, J., Yang, D., et al. (2019) · Translational Stroke Research · doi:10.1007/s12975-019-00772-1 · Cited by 95
Effects of glycyrrhizin on lipopolysaccharide-induced acute lung injury in a mouse model
Lee, S. A., Lee, S. H., Kim, J. Y., & Lee, W. S. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.04.14 · Cited by 94
Cao, Z., Liu, Y., Li, J., Ruan, Y., Yan, W., Zhong, S.-Y., Zhang, T., Liu, L.-L., Wu, R., Wang, B., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.048 · Cited by 93
Ochi, M. M., Amoabediny, G., Rezayat, S. M., Akbarzadeh, A., & Ebrahimi, B. (2016) · Europe PMC (PubMed Central) · doi:10.22074/cellj.2016.4308 · Cited by 92
Fu, Y., Zhou, E., Wei, Z., Liang, D., Wang, W., Wang, T., Guo, M., Zhang, N., & Yang, Z. (2014) · FEBS Journal · doi:10.1111/febs.12801 · Cited by 91
Porcine Epidemic Diarrhea Virus Induces Autophagy to Benefit Its Replication
Guo, X., Zhang, M., Zhang, X., Tan, X., Guo, H., Zeng, W., Yan, G., Memon, A. M., Li, Z., Zhu, Y., et al. (2017) · Viruses · doi:10.3390/v9030053 · Cited by 87
Involvement of Autophagy in Coronavirus Replication
Maier, H. J., & Britton, P. (2012) · Viruses · doi:10.3390/v4123440 · Cited by 85
High-Mobility Group Box 1 Protein Signaling in Painful Diabetic Neuropathy
Thakur, V., Sadanandan, J., & Chattopadhyay, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030881 · Cited by 83
Zheng, L., Zhu, Q., Xu, C., Li, M., Li, H., Yi, P., Xu, F., Cao, L., & Chen, J. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14703 · Cited by 80
Wang, Y.-T., Zhao, B., Wang, S., Liang, Q., Cai, Y., Yang, F., & Li, G. (2016) · Drug Delivery · doi:10.3109/10717544.2015.1135489 · Cited by 77
Saponins from European Licorice Roots ( Glycyrrhiza glabra).
Schmid, C., Dawid, C., Peters, V., & Hofmann, T. (2018) · Journal of Natural Products · doi:10.1021/acs.jnatprod.8b00022 · Cited by 76
Wan, Z., Sun, Y., Ma, L., Zhou, F., Guo, J., Hu, S., & Yang, X. (2018) · Langmuir · doi:10.1021/acs.langmuir.8b00128 · Cited by 75
Petramfar, P., Hajari, F., Yousefi, G., Azadi, S., & Hamedi, A. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112226 · Cited by 74
Ugrinova, I., & Pasheva, E. A. (2016) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2016.10.001 · Cited by 73
Managò, A., Audrito, V., Mazzola, F., Sorci, L., Gaudino, F., Gizzi, K., Vitale, N., Incarnato, D., Minazzato, G., Ianniello, A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12055-2 · Cited by 73
Sviridov, D., Mukhamedova, N., Makarov, A. А., Adzhubei, A. A., & Bukrinsky, M. (2019) · AIDS · doi:10.1097/qad.0000000000002385 · Cited by 73
Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic
Torres, T. R., & Puig, L. (2020) · American Journal of Clinical Dermatology · doi:10.1007/s40257-020-00514-2 · Cited by 72
Autophagy: The multi‐purpose bridge in viral infections and host cells
Abdoli, A., Alirezaei, M., Mehrbod, P., & Forouzanfar, F. (2018) · Reviews in Medical Virology · doi:10.1002/rmv.1973 · Cited by 71
Coviello, T., Trotta, A. M., Marianecci, C., Carafa, M., Di Marzio, L., Rinaldi, F., Di Meo, C., Alhaique, F., & Matricardi, P. (2015) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2014.10.060 · Cited by 70 · cited 1×
“Improvements have been proposed to further ameliorate the stability, skin permeability and capacity of these niosomes to deliver the drug, with the use of gel-forming polysaccharides (Coviello et al., 2015).”
Wang, C., Su, X., Sun, M., Zhang, M., Wu, J., Xing, J., Wang, Y., Xue, J., Liu, X., Sun, W., et al. (2019) · Microbial Cell Factories · doi:10.1186/s12934-019-1138-5 · Cited by 69
Glycyrrhizin ameliorates atopic dermatitis-like symptoms through inhibition of HMGB1
Wang, Y., Zhang, Y., Peng, G., & Han, X. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.04.029 · Cited by 66
Melki, M., Saïdi, H., Dufour, A., Olivo‐Marín, J., & Gougeon, M. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000862 · Cited by 65
Le, Y., Wang, Y., Zhou, L., Xiong, J., Tian, J., Yang, X., Gai, X., & Sun, Y. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14789 · Cited by 65
Glycyrrhizic acid derivatives as Dengue virus inhibitors
Балтина, Л. А., Tasi, Y.-T., Huang, S.-H., Lai, H., Baltina, L. A., Petrova, S. F., Yunusov, M. S., & Lin, C. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.126645 · Cited by 64
Kratschmar, D. V., Vuorinen, A., Cunha, T. D., Wolber, G., Classen-Houben, D., Doblhoff, O., Schuster, D., & Odermatt, A. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.12.019 · Cited by 63
Ding, H., Deng, W., Ding, L., Ye, X., Yin, S., & Huang, W. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26064 · Cited by 63
Glycyrrhizic acid ameliorates the kynurenine pathway in association with its antidepressant effect
Wang, B., Lian, Y., Dong, X. W., Wei, P., Liu, L.-L., Su, W., Gong, H., Zhang, T., Jiang, C., Li, J., et al. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.01.024 · Cited by 62
Shi, X., Yu, L., Zhang, Y., Liu, Z., Zhang, H., Zhang, Y., Liu, P., & Du, P. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106578 · Cited by 61
Zhang, Y., Song, Z., Wang, M., Lan, M., Zhang, K., Jiang, P., Li, Y., Bai, J., & Wang, X. (2019) · Veterinary Microbiology · doi:10.1016/j.vetmic.2019.03.004 · Cited by 59
Cao, Y., Shi, H., Sun, Z., Wu, J., Xia, Y., Wang, Y., Wu, Y., Li, X., Chen, W., Wang, A., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00119 · Cited by 59
Saikosaponin A inhibits influenza A virus replication and lung immunopathology
Chen, J., Duan, M., Zhao, Y., Ling, F., Xiao, K., Li, Q., Li, B., Lu, C., Qi, W., Zeng, Z., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6448 · Cited by 58
The antiviral effects of acteoside and the underlying IFN-γ-inducing action
Song, X., He, J., Xu, H. Y., Hu, X.-P., Wu, X.-L., Wu, H.-Q., Liu, L.-Z., Liao, C.-H., Zeng, Y., Li, Y., et al. (2016) · Food & Function · doi:10.1039/c6fo00335d · Cited by 58
Li, J., Yin, J., Sui, X., Li, G., & Ren, X. (2009) · Avian Pathology · doi:10.1080/03079450902912184 · Cited by 56
Chang, H., Chen, S.-Y., Wu, C., Lu, C., & Yen, G. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b00251 · Cited by 56
Real-time analysis of membrane permeabilizing effects of oleanane saponins
Gilabert‐Oriol, R., Mergel, K., Thakur, M., von Mallinckrodt, B., Melzig, M. F., Fuchs, H., & Weng, A. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.01.061 · Cited by 55
Li, Z., Zhao, K., Lan, Y., Lv, X., Hu, S., Guan, J., Lu, H., Zhang, J., Shi, J., Yang, Y., et al. (2017) · Journal of Virology · doi:10.1128/jvi.01083-17 · Cited by 55
Tan, Q.-Y., Hu, Q., Zhu, S., Jia, L.-L., Xiao, J., Su, H., Huang, S., Zhang, J., & Jin, J. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1472676 · Cited by 55
Chen, J., Zhang, Z., Song, J., Liu, Q., Wang, C., Huang, Z., Chu, L., Liang, H., Zhang, B., & Chen, X. (2018) · Scientific Reports · doi:10.1038/s41598-018-27142-5 · Cited by 55
Li, X., Yue, Y., Zhu, Y., & Xiong, S. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.01.023 · Cited by 54
Huan, C., Wang, H.-X., Sheng, X.-X., Wang, R., Wang, X., & Mao, X. (2017) · Archives of Virology · doi:10.1007/s00705-017-3259-7 · Cited by 54
Antiviral and immune stimulant activities of glycyrrhizin against duck hepatitis virus
Soufy, H., Yassein, S., Ahmed, A., Khodier, M. H., Kutkat, M. A. A., Nasr, S. M., & Okda, F. A. (2012) · African Journal of Traditional Complementary and Alternative Medicines · doi:10.4314/ajtcam.v9i3.14 · Cited by 52
Fu, Y., Zhou, E., Wei, Z., Song, X., Liu, Z., Wang, T., Wang, W., Zhang, N., Liu, G., & Yang, Z. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.01.024 · Cited by 52
Role of ROS and HMGB1 in Contact Allergen–Induced IL-18 Production in Human Keratinocytes
Galbiati, V., Papale, A., Galli, C. L., Marinovich, M., & Corsini, E. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.203 · Cited by 52
Saïdi, H., Melki, M., & Gougeon, M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003601 · Cited by 51
Glycyrrhizin Suppresses the Growth of Human NSCLC Cell Line HCC827 by Downregulating HMGB1 Level
Wu, X., Wang, W., Chen, Y., Liu, X., Wang, J., Qin, X., Yuan, D., Yu, T., Chen, G., Mi, Y.-Y., et al. (2018) · BioMed Research International · doi:10.1155/2018/6916797 · Cited by 50
Ma, L., Li, Q., Du, Z., Su, E., Liu, X., Wan, Z., & Yang, X. (2019) · Advanced Materials Interfaces · doi:10.1002/admi.201900417 · Cited by 50
Stepwise Release of Biologically Active HMGB1 during HSV-2 Infection
Borde, C., Barnay‐Verdier, S., Gaillard, C., Hocini, H., Maréchal, V., & Gozlan, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016145 · Cited by 49
Wagle, A., Seong, S. H., Zhao, B. T., Woo, M. H., Jung, H. A., & Choi, J. S. (2018) · Archives of Pharmacal Research · doi:10.1007/s12272-018-1018-2 · Cited by 49
Yang, G., Li, J., Cai, Y., Yang, Z., Li, R., & Fu, W. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2609-5 · Cited by 49
Inhibition of Intercellular Adhesion in Herpex Simplex Virus Infection by Glycyrrhizin
Huang, W., Chen, X., Li, Q., Li, P., Zhao, G., Xu, M., & Xie, P. (2011) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-011-9271-8 · Cited by 48
Song, Z., Zhang, Q., Liu, X., Bai, J., Zhao, Y., Wang, X., & Jiang, P. (2017) · Veterinary Microbiology · doi:10.1016/j.vetmic.2017.09.011 · Cited by 48
Kim, A. V., Shelepova, E. A., Selyutina, O. Y., Meteleva, E. S., Dushkin, A. V., Medvedev, N. N., Polyakov, N. E., & Lyakhov, N. Z. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00390 · Cited by 48
Zhang, D., Liu, B., Cao, B., Wei, F., Yu, X., Li, G., Chen, H., Wei, L., & Wang, P.-L. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.04.024 · Cited by 47
Mou, K., Pan, W., Han, D., Wen, X., Cao, F., Miao, Y., & Li, P. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4200 · Cited by 46
Cai, J., Luo, S., Lv, X., Deng, Y., Huang, H., Zhao, B., Zhang, Q., & Li, G. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118693 · Cited by 46
Ochratoxin A-induced autophagy in vitro and in vivo promotes porcine circovirus type 2 replication
Qian, G., Liu, D., Hu, J., Gan, F., Hou, L., Chen, X., & Huang, K. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.303 · Cited by 45
The Interaction between Nidovirales and Autophagy Components
Cong, Y., Verlhac, P., & Reggiori, F. (2017) · Viruses · doi:10.3390/v9070182 · Cited by 45
He, H., Wei, D., Liu, H., Zhu, C. Y., Lu, Y. P., Ke, Z., Jiang, S., & Huang, J. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14246 · Cited by 45
Sakamoto, S., Nakahara, H., Uto, T., Shoyama, Y., & Shibata, O. (2013) · Biochimica et Biophysica Acta · doi:10.1016/j.bbamem.2013.01.006 · Cited by 42
Ding, N., Zhao, K., Lan, Y., Li, Z., Lv, X., Su, J., Lu, H., Gao, F., & He, W. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00056 · Cited by 41
Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence
Roustit, M., Guilhaumou, R., Molimard, M., Drici, M., Laporte, S., & Montastruc, J. (2020) · Therapies · doi:10.1016/j.therap.2020.05.010 · Cited by 41
Chen, Q., Chen, H., Wang, W., Liu, J., Liu, W., Ni, P., Sang, G., Wang, G., Zhou, F., & Zhang, J. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.06.015 · Cited by 40
Lee, S. H., Bae, I., Choi, H., Choi, H. W., Oh, S., Marinho, P. A., Min, D. J., Kim, D.-Y., Lee, T. R., Lee, C. S., et al. (2018) · Archives of Dermatological Research · doi:10.1007/s00403-018-1883-z · Cited by 40
Advances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19
Sun, J., Chen, Y., Fan, X., Wang, X., Han, Q., & Liu, Z. (2020) · Postgraduate Medicine · doi:10.1080/00325481.2020.1778982 · Cited by 40
Gao, M., Li, X., He, L., Yang, J., Ye, X., Xiao, F., & Wei, H. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s220030 · Cited by 39
Repurposing Papaverine as an Antiviral Agent against Influenza Viruses and Paramyxoviruses
Aggarwal, M., Leser, G. P., & Lamb, R. A. (2020) · Journal of Virology · doi:10.1128/jvi.01888-19 · Cited by 39
Du, D., Yan, J., Ren, J., Lv, H., Li, Y., Xu, S., Wang, Y., Ma, S., Qu, J., Tang, W., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301248y · Cited by 38
Umar, S. A., Tanveer, M. A., Nazir, L. A., Divya, G., Vishwakarma, R. A., & Abdullah, S. T. (2019) · Cellular Physiology and Biochemistry · doi:10.33594/000000133 · Cited by 38
Yamaguchi, H., Kidachi, Y., Kamiie, K., Noshita, T., & Umetsu, H. (2012) · Bioinformation · doi:10.6026/97320630081147 · Cited by 37
Tamada, K., Nakajima, S., Ogawa, N., Inada, M., Shibasaki, H., Sato, A., Takasawa, R., Yoshimori, A., Suzuki, Y., Watanabe, N., et al. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.01.136 · Cited by 37
Zou, X., Wang, Y., Peng, C. Y., Wang, B., Niu, Z., Li, Z., & Niu, J. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3787 · Cited by 36
Shen, S., Zhou, M., Huang, K., Wu, Y., Ma, Y., Wang, J., Ma, J., & Fan, S. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.441 · Cited by 35
Shakeri, A., Masullo, M., D’Urso, G., Iranshahi, M., Montoro, P., Pìzza, C., & Piacente, S. (2017) · Food Chemistry · doi:10.1016/j.foodchem.2017.12.031 · Cited by 35
Jeon, Y. R., Roh, H., Jung, J. H., Ahn, H. M., Lee, J. H., Yun, C., & Lee, W. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174134 · Cited by 34
HMGB1 mediates the development of tendinopathy due to mechanical overloading
Zhao, G., Zhang, J., Nie, D., Zhou, Y., Li, F., Onishi, K., Billiar, T. R., & Wang, J. H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222369 · Cited by 34
Ramli, E. S. M., Suhaimi, F., Asri, S. F. M., Ahmad, F., & Soelaiman, I. (2013) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-012-0413-x · Cited by 33
Yoshida, Y., Fujigaki, H., Kato, K., Yamazaki, K., Fujigaki, S., Kunisawa, K., Yamamoto, Y., Mouri, A., Oda, A., Nabeshima, T., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-46666-y · Cited by 33
Induction of high-mobility group Box-1 in vitro and in vivo by respiratory syncytial virus
Manti, S., Harford, T. J., Salpietro, C. D., Rezaee, F., & Piedimonte, G. (2018) · Pediatric Research · doi:10.1038/pr.2018.6 · Cited by 31
Using glycyrrhizic acid to target sumoylation processes during Epstein-Barr virus latency
Bentz, G. L., Lowrey, A. J., Horne, D. C., Nguyen, V., Satterfield, A. R., Ross, T., Harrod, A. E., Uchakina, O. N., & McKallip, R. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217578 · Cited by 31
Study on the interaction of glycyrrhizin and glycyrrhetinic acid with RNA
Nafisi, S., Manouchehri, F., & Bonsaii, M. (2012) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2012.03.006 · Cited by 30
HMGB1 regulates IL-33 expression in acute respiratory distress syndrome
Fu, J., Lin, S., Wang, C., Li, S.-Y., Feng, X.-Y., Liu, Q., & Xu, F. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.06.010 · Cited by 29
Fotoran, W. L., Müntefering, T., Kleiber, N., de Miranda, B. N. M., Liebau, E., Irvine, D. J., & Wunderlich, G. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.102099 · Cited by 29
Clinical spectrum of acute sporadic hepatitis E and possible benefit of glycyrrhizin therapy
Tandon, A. (2002) · Hepatology Research · doi:10.1016/s1386-6346(01)00155-3 · Cited by 27
Yu, W., Jin, H., Shen, A., Deng, L., Shi, J., Xue, X., Guo, Y., Liu, Y., & Liang, X. (2016) · Journal of Chromatography B · doi:10.1016/j.jchromb.2016.11.031 · Cited by 26
Suzuki, T., Tsukahara, M., Akasaka, Y., & Inoue, H. (2017) · Biomedical Chromatography · doi:10.1002/bmc.4032 · Cited by 26
Proposed mechanisms for the extracellular release of PD-L1 by the anticancer saponin platycodin D
Bailly, C., & Vergoten, G. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106675 · Cited by 25
Self-citationSong, Z., Bai, J., Nauwynck, H., Lv, L., Liu, X., Yu, J., & Jiang, P. (2019) · Veterinary Microbiology · doi:10.1016/j.vetmic.2019.02.035 · Cited by 24
Li, W., Li, Y., Jiang, X., Li, X., & Yu, Z. (2018) · Molecules · doi:10.3390/molecules23092378 · Cited by 23
Li, Z., Zhao, Y. V., Lin, W., Ye, M., & Ling, X. (2015) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2015.02.021 · Cited by 21
Tanaka, N., Horiuchi, A., Yamaura, T., Komatsu, M., Yokoyama, T., Okaniwa, S., Nagaya, T., Yoshizawa, K., Kiyosawa, K., Aoyama, T., et al. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-009-0034-x · Cited by 20
Wang, B., Mao, Y.-L., Gong, L., Xu, X., Jiang, S., Wang, Y.-B., & Li, W. (2018) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1700506 · Cited by 20
Interaction of Glycyrrhizin and Glycyrrhetinic Acid with DNA
Nafisi, S., Bonsaii, M., Manouchehri, F., & Abdi, K. (2011) · DNA and Cell Biology · doi:10.1089/dna.2011.1287 · Cited by 19
Macmoondongtang modulates Th1-/Th2-related cytokines and alleviates asthma in a murine model
Lee, S. Y., Kang, B., Bok, S., Cho, S., & Park, D.-H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224517 · Cited by 19
Yu, S., Yin, C., Song, K., Su, L., Zheng, G.-L., Li, L., Wang, J., Li, Y., Luo, Y., Sun, Y., et al. (2018) · Journal of General Virology · doi:10.1099/jgv.0.001178 · Cited by 18
Huan, C.-C., Wang, H.-X., Sheng, X.-X., Wang, R., Wang, X., Liao, Y., Liu, Q.-F., Tong, G.-Z., Ding, C., Fan, H.-J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11991 · Cited by 17
Li, W., Guo, F., Jiang, X., Li, Y., Li, X., & Yu, Z. (2019) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2019.108585 · Cited by 17
Андреевич, В. В., Salakhutdinov, N. F., Ragino, Y. I., Polyakov, N. E., Taraban, M. B., Leshina, T. V., Stakhneva, E. M., Lyakhovich, V. V., IuP, N., & Толстиков, Г. А. (2008) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750808040070 · Cited by 15
Synergistic effect of tolfenamic acid and glycyrrhizic acid on TPA-induced skin inflammation in mice
Liu, W., Huang, S., Li, Y., Zheng, X., & Zhang, K. (2019) · MedChemComm · doi:10.1039/c9md00345b · Cited by 14
Cited by
Zeng, J., Bao, T., Yang, K., Zhu, X., Wang, S., Xiang, W., Ge, A., Zeng, L., & Ge, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1047550 · Cited by 175
Husain, I., Bala, K., Khan, I. A., & Khan, S. I. (2021) · Food Frontiers · doi:10.1002/fft2.110 · Cited by 104
Xu, M., Wan, Z., & Yang, X. (2021) · Molecules · doi:10.3390/molecules26196075 · Cited by 48
Metadata
- Authors
- Bailly, C., & Vergoten, G.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2020-10
- Volume
- 214
- Pages
- 107618
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W3036970257
- Cited by
- 301
- References
- 177
- FWCI
- 47.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.